MRI volumetric and 31P MRS metabolic correlates of caudate nucleus in antipsychotic-naïve schizophrenia

Acta Psychiatrica Scandinavica

Volumn 114, Issue 5, 2006, Pages 346-351

  Jayakumar, P N ^a   Venkatasubramanian, G ^a   Keshavan, M S ^b   Srinivas, J S ^a   Gangadhar, B N ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

31P magnetic resonance spectroscopy; Caudate; Magnetic resonance imaging; Schizophrenia

Indexed keywords

ADENOSINE TRIPHOSPHATE; CREATINE PHOSPHATE; NEUROLEPTIC AGENT; PHOSPHORUS; PSYCHOTROPIC AGENT;

ADULT; ARTICLE; BASAL GANGLION; BRAIN METABOLISM; BRAIN SIZE; CAUDATE NUCLEUS; CLINICAL ARTICLE; COMPARATIVE STUDY; COMPUTER PROGRAM; CONTROLLED STUDY; CORRELATION ANALYSIS; CORRELATIONAL STUDY; FEMALE; HUMAN; MALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PSYCHOSIS; SCHIZOPHRENIA; CORPUS STRIATUM; HEMISPHERIC DOMINANCE; HISTOLOGY; METABOLISM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADENOSINE TRIPHOSPHATE; ADULT; BASAL GANGLIA; CAUDATE NUCLEUS; CORPUS STRIATUM; FEMALE; FUNCTIONAL LATERALITY; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; PHOSPHOCREATINE; PHOSPHORUS; PSYCHOTROPIC DRUGS; SCHIZOPHRENIA;

EID: 33749466139     PISSN: 0001690X     EISSN: 16000447     Source Type: Journal    
DOI: 10.1111/j.1600-0447.2006.00836.x     Document Type: Article

References (26)

1. CHUA SE, LAM IW, TAI KS et al. Brain morphological abnormality in schizophrenia is independent of country of origin. Acta Psychiatr Scand 2003;108:269-275.
2. JESTE DV, MCADAMS LA, PALMER BW et al. Relationship of neuropsychological and MRI measures to age of onset of schizophrenia. Acta Psychaitr Scand 1998;98:156-164.
3. BUSATTO GF, KERWIN RW. Schizophrenia, psychosis, and the basal ganglia. Psychiatry Clin North Am 1997;20:897-910.
4. RING HA, SERRA-MESTRES J. Neuropsychiatry of the basal ganglia. J Neurol Neurosurg Psychiatry 2002;72:12-21.
5. SHENTON ME, DICKEY CC, FRUMIN M, MCCARLEY RW. A review of MRI findings in schizophrenia. Schizophr Res 2001;49:1-52.
6. BROWN KW, WARDLAW JM, WHITE T, WALKER N. Caudate nucleus area in drug-induced parkinsonism. Acta Psychiatr Scand 1996;94:348-351.
7. KESHAVAN MS, ROSENBERG D, SWEENEY JA, PETTEGREW JW. Decreased caudate volume in neuroleptic-naïve psychotic patients. Am J Psychiatry 1998;155:774-778.
8. SHIHABUDDIN L, BUCHSBAUM MS, HAZLETT EA. Dorsal striatal size, shape, and metabolic rate in never-medicated and previously medicated schizophrenics performing a verbal learning task. Arch Gen Psychiatry 1998;55:235-243.
9. VENKATASUBRAMANIAN G, GANGADHAR BN, JAYAKUMAR PN, JANAKIRAMAIAH N, KESHAVAN MS. Striato-cerebellar abnormalities in never-treated schizophrenia: evidence for neurodevelopmental etiopathogenesis. German J Psychiatry 2003;6:1-7.
10. DEICKEN RF, CALABRESE G, MERRIN EL, FEIN G, WEINER MW. Basal ganglia phosphorous metabolism in chronic schizophrenia. Am J Psychiatry 1995;152:126-129.
11. FUJIMOTO T, NAKANO T, TAKANO T, HOKAZONO Y. Study of chronic schizophrenics using 31P magnetic resonance chemical shift imaging. Acta Psychiatr Scand 1992;86:455-462.
12. 31P magnetic resonance spectroscopic study of basal ganglia in drug naive first episode schizophrenia. Am J Psychiatry 2004;161:1304-1306.
13. World Health Organization. Schedules for Clinical Assessment in Neuropsychiatry (version 2.1). Geneva: World Health Organization, 1998.
14. HAFNER H, RIECHER-ROSSLER A, HAMBRECHT M et al. IRAOS: an instrument for the retrospective assessment of the onset of schizophrenia. Schizophr Res 1992;6:209-223.
15. KAY SR, FIZBEIN A, OPLER A. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull 1987;2:261-276.
16. GOLDBERG DP, GATER R, SARTORIUS N et al. The validity of two versions of the GHQ in the WHO study of mental illness in general health care. Psychol Med 1997;7:191-197.
17. ANNETT M. The binomial distribution of right, mixed and left-handedness. Q J Exp Psychol 1967;19:327-333.
18. GUY W. Abnormal Involuntary Movements Scale (AIMS). ECDEU Assessment Manual for Pharmacology. Rockville, MD: US Dept of Health, Education, and Welfare, 1976.
19. SIMPSON GM, ANGUS JWS. A rating scale for extrapyramidal side effects. Acta Psychiatr Scand Suppl 1970;212:11-19.
20. KESHAVAN MS, ANDERSON S, BECKWITH C, NASH K, PETTERGREW J, KRISHNAN KRR. A comparison of stereology and segmentation techniques for volumetric measurements of brain ventricles. Psychiatry Res Neuroimag 1995;61:53-60.
21. ANANTH H, POPESCU I, CRITCHLEY HD, GOOD CD, FRACKOWIAK RSJ, DOLAN RJ. Cortical and subcortical gray matter abnormalities in schizophrenia determined through structural magnetic resonance imaging with optimized volumetric voxel-based morphometry. Am J Psychiatry 2002;159:1497-1505.
22. CHAKOS MH, LIEBERMAN JA, BILDER RM. Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs. Am J Psychiatry 1997;151:1430-1436.
23. O'NEILL J, LEVITT J, CAPLAN R et al. 1H MRSI evidence of metabolic abnormalities in childhood-onset schizophrenia. Neuroimage 2004;21:1781-1789.
24. JERNIGAN TL, ZISOOK S, HEATON RK, MORANVILLE JT, HESSELINK JR, BRAFF DL. Magnetic resonance imaging abnormalities in lenticular nuclei and cerebral cortex in schizophrenia. Arch Gen Psychiatry 1991;48:881-890
25. FEINBERG I. Schizophrenia: caused by a fault in programmed synaptic elimination during adolescence? J Psychiatr Res 1983;17:319-334.
26. KLUNK WE, XU CJ, PANCHALINGAM K, MCCLURE RJ, PETTEGREW JW. Analysis of magnetic resonance spectra by mole percent: comparison of absolute units. Neurobiol Aging 1994;15:133-134.